• Email Us: [email protected]
  • Contact Us: +1 718 618 4351
  • Skip to content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

U.S. SEC questions funds over ESG labels – Bloomberg News

September 3, 2021 by David Barret Leave a Comment

September 3, 2021

(Reuters) – The U.S. securities regulator has been asking money managers to explain the standards they use for classifying funds as environmental, social and governance (ESG)-focused for several months, Bloomberg News reported, citing people familiar with the matter.

This is the second such review by the U.S. Securities and Exchange Commission (SEC) after the regulator in April found “potentially misleading” claims and inadequate controls around investing in ESG issues in a review of investment advisors and funds. https://reut.rs/3yHrpLx

Investment advisers were asked to describe in “painstaking detail” the screening processes they use to ensure assets are worthy of ESG designations, according to the report on Friday. https://bloom.bg/3gZLhTU

Another SEC query sought information on ESG compliance programs, policies and procedures, the report said, citing a different source.

(Reporting by Noor Zainab Hussain in Bengaluru; Editing by Shinjini Ganguli)

Source Link U.S. SEC questions funds over ESG labels – Bloomberg News

Related posts:

  1. Tennis – Azarenka calls for mandatory COVID-19 vaccinations
  2. Daimler expects Mercedes Q3 sales significantly below Q2 – report
  3. Motor racing-Bottas rules out imminent announcement on his F1 future
  4. U.S. to give Ukraine more than $45 million in additional humanitarian aid -Blinken

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar


  • Home
  • All Reports
  • About Us
  • Contact Us
  • +1 718 618 4351
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2022 · Medical Market Report. All Rights Reserved.

Go to mobile version